Chemoprotection by VEGF: Rationale for combination nab-paclitaxel and bevacizumab
Year: 2007
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: V. Trieu, S. Ran, C. Bivens, N. Desai
Institutions: SIU Medicine, Abraxis (United States)
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2261484844
